SLN

Conviction 100HealthcareScan · Thu, Jun 25, 2026

SLN$9.99+9.06%

ResistanceSupportVol 14

Vol MA14 501.49K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Silence Therapeutics plcPHARMACEUTICAL PREPARATIONSwww.silence-therapeutics.com ↗

Price9.99

Change+9.06%

Gap+0.55%

Rel volume3.66×

Avg volume406.68K

Avg $ vol3.23M

SMA 206.95

SMA 507.04

SMA 2006.15

Price vs 50+41.92%

Price vs 200+62.38%

MA stackbullish

50/200 cross—

Supertrendup · 7.36

RSI (14)76

MACD hist0.34

MACD crossbull · 8d

Stoch %K / %D95 / 85

ADX (14)27

+DI / −DI41 / 6

RSI divergence—

MACD divergence—

ATR %+7.23%

ADR %9.29%

52w high9.99

52w low4.30

From 52w high+0.00%

Above 52w low+132.33%

New 52w highYes

SqueezeOff

Bollinger width55.39%

%B1.29

Donchian pos95.36%

Donchian high10.19

Donchian low5.88

AVWAP (52w high)9.80

vs AVWAP high+1.97%

AVWAP (52w low)6.76

vs AVWAP low+47.72%

OBV trendUp

Chaikin MF (20)0.33

Today vs 20d3.66×

Avg vol (14d)501.49K

Avg vol (20d)406.68K

Avg $ vol (20d)3.23M

Market cap1.42B

RS 3m (vs SPY)+63.90%

RS 6m (vs SPY)+36.06%

RS line new highYes

Trend template8/8

Technical rank95.4

1 week+47.78%

1 month+50.45%

3 months+82.63%

6 months+54.88%

1 year+65.26%

YTD+62.44%

P/E-15.98

P/B28.66

P/S—

P/FCF-22.71

EPS-0.6300

Div yield—

ROE-179.37%

ROA-76.97%

Debt/Eq—

Current9.83

EV/EBITDA—

Gross margin61.54%

Net margin—

Rev growth-98.71%

EPS growth-95.57%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.41B

Revenue422K

Net income-14.96M

Gross profit411K

Free cash flow-62.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out47.23M

Employees88

ListedTue, Sep 8, 2020

Free float20.64M

Float %14.6%

Short interest2.06M

Days to cover9.1d

Short volume16.6%

Squeeze score60 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.32 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank95.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance7.48

Support5.81

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLN

All disclosures →

No recent disclosed trades by Congress in SLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLN

No recent insider (Form 4) filings in SLN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SLN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.